Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

CD40L + CD8 + T-Cell Dependent Antitumor Immunity

Andreas Thiel, PhD, Marco Frentsch, Joanna Listopad, Regina Stark, Alberto Sada Japp, Nadine Matzmohr, Sarah Meier, Ichiro Taniuchi, MD PhD, Thomas Blankenstein, PhD

Blood (2014) 124 (21): 5818.

https://doi.org/10.1182/blood.V124.21.5818.5818

Published: 2014

Journal Articles

Inherent CD40L Expression Complements CD8 + T Cell Dependent Anti-Tumor Immunity

Andreas Thiel, PhD, Marco Frentsch, Regina Stark, Alberto Sada Japp, Joanna Listopad, Nadine Matzmohr, Sarah Meier, Dirk Busch, Axel Schulz, Thomas Blankenstein

Blood (2013) 122 (21): 4494.

https://doi.org/10.1182/blood.V122.21.4494.4494

Published: 2013

Journal Articles

CD40L expression permits CD8 + T cells to execute immunologic helper functions

Marco Frentsch, Regina Stark, Nadine Matzmohr, Sarah Meier, Sibel Durlanik, Axel R. Schulz, Ulrik Stervbo, Karsten Jürchott, Friedemann Gebhardt, Guido Heine, Morgan A. Reuter, Michael R. Betts, Dirk Busch, Andreas Thiel

Blood (2013) 122 (3): 405–412.

https://doi.org/10.1182/blood-2013-02-483586

Published: 2013

Includes: Supplemental data

Journal Articles

High Efficiency Isolation of Alloantigen-Reactive Foxp3 + Natural Regulatory T Cells According to Specific Activation Marker Signatures

Anne Schoenbrunn, Jacqueline Keye, Siegfried Kohler, Marco Frentsch, Beate Moewes, Alexander Scheffold, Chiara Romagnani, Andreas Thiel

Blood (2011) 118 (21): 1915.

https://doi.org/10.1182/blood.V118.21.1915.1915

Published: 2011

Journal Articles

CD62L expression identifies a unique subset of polyfunctional CD56 dim NK cells

Kerstin Juelke, Monica Killig, Merlin Luetke-Eversloh, Eliana Parente, Joachim Gruen, Barbara Morandi, Guido Ferlazzo, Andreas Thiel, Isabela Schmitt-Knosalla, Chiara Romagnani

Blood (2010) 116 (8): 1299–1307.

https://doi.org/10.1182/blood-2009-11-253286

Published: 2010

Includes: Supplemental data

Journal Articles

Cytokine-induced human IFN-γ–secreting effector-memory Th cells in chronic autoimmune inflammation

Arne Sattler, Ulf Wagner, Manuela Rossol, Joachim Sieper, Peihua Wu, Andreas Krause, Wolfgang A. Schmidt, Sebastian Radmer, Siegfried Kohler, Chiara Romagnani, Andreas Thiel

Blood (2009) 113 (9): 1948–1956.

https://doi.org/10.1182/blood-2008-02-139147

Published: 2009

Journal Articles

Life after the thymus: CD31 + and CD31 − human naive CD4 + T-cell subsets

Siegfried Kohler, Andreas Thiel

Blood (2009) 113 (4): 769–774.

https://doi.org/10.1182/blood-2008-02-139154

Published: 2009

Journal Articles

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system

Tobias Alexander, Andreas Thiel, Oliver Rosen, Gero Massenkeil, Arne Sattler, Siegfried Kohler, Henrik Mei, Hartmut Radtke, Erika Gromnica-Ihle, Gerd-Rüdiger Burmester, Renate Arnold, Andreas Radbruch, Falk Hiepe

Blood (2009) 113 (1): 214–223.

https://doi.org/10.1182/blood-2008-07-168286

Published: 2009

Journal Articles

Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses

Mariella Della Chiesa, Chiara Romagnani, Andreas Thiel, Lorenzo Moretta, Alessandro Moretta

Blood (2006) 108 (12): 3851–3858.

https://doi.org/10.1182/blood-2006-02-004028

Published: 2006

Journal Articles

Treatment of Adenovirus Infection by Adoptive Immunotherapy: Adenovirus Capsid Hexon Is the Main Target Protein of Adenovirus-Specific Cellular Immunity.

Olga Arbach, MD, Marco Frentsch, PhD, Barbara Chmielewicz, PhD, Marco Kaiser, PhD, Heinz Ellerbrock, PhD, Roland Lauster, PhD, Renate Arnold, MD, Andreas Radbruch, PhD, Sebastian Voigt, MD, Wolfram Ebell, MD, Andreas Thiel, PhD

Blood (2006) 108 (11): 2930.

https://doi.org/10.1182/blood.V108.11.2930.2930

Published: 2006

Journal Articles

Adenovirus Capsid Hexon Is the Main Target Protein of Adenovirus-Specific CD4 + T-Cells: Fundamentals for Targeting Adenovirus by Adoptive Immunotherapy.

Olga Arbach, MD, Marco Frentsch, Sebastian Voigt, MD, Barbara Chmielewicz, PhD, Marco Kaiser, Heins Ellerbrok, PhD, Roland Lauster, PhD, Andreas Radbruch, PhD, Alexander Scheffold, PhD, Wolfram Ebell, MD, Andreas Thiel, PhD

Blood (2005) 106 (11): 3034.

https://doi.org/10.1182/blood.V106.11.3034.3034

Published: 2005

NARROW

CD40L + CD8 + T-Cell Dependent Antitumor Immunity

Inherent CD40L Expression Complements CD8 + T Cell Dependent Anti-Tumor Immunity

CD40L expression permits CD8 + T cells to execute immunologic helper functions

High Efficiency Isolation of Alloantigen-Reactive Foxp3 + Natural Regulatory T Cells According to Specific Activation Marker Signatures

CD62L expression identifies a unique subset of polyfunctional CD56 dim NK cells

Cytokine-induced human IFN-γ–secreting effector-memory Th cells in chronic autoimmune inflammation

Life after the thymus: CD31 + and CD31 − human naive CD4 + T-cell subsets

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system

Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses

Treatment of Adenovirus Infection by Adoptive Immunotherapy: Adenovirus Capsid Hexon Is the Main Target Protein of Adenovirus-Specific Cellular Immunity.

Adenovirus Capsid Hexon Is the Main Target Protein of Adenovirus-Specific CD4 + T-Cells: Fundamentals for Targeting Adenovirus by Adoptive Immunotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only